跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 21,921 条关于
“MingMed Biotechnology Co., Ltd”
全部
21,921
临床试验
4,352
药物
2,404
机构
4,502
资讯
10,663
4个月前
MingMed Biotechnology's QA102 Shows Promise in Phase II Trial for Intermediate Dry AMD
2年前
Fosun Pharma and MingMed Achieve Key Regulatory Milestones for Novel Therapies
去年
Eisai Advances LEQEMBI Subcutaneous and IV Maintenance Dosing Applications for Alzheimer's Disease
去年
AIM Vaccine Submits 13-Valent Pneumonia Conjugate Vaccine for Approval After Positive Phase III Results
去年
Rege Nephro Secures $150 Million in Series B Funding to Advance Kidney Disease Therapies
去年
Lumosa Therapeutics' LT3001 Shows Promise in Phase II Acute Ischemic Stroke Trial
2年前
Epsilogen Completes Series B Expansion to Advance IgE Antibody Therapy for Ovarian Cancer
去年
Dizal Submits NDA to FDA for Sunvozertinib in EGFR Exon20ins NSCLC
去年
Newron Pharmaceuticals Expands Evenamide Reach in Asia with New Licensing Agreements
去年
AIM Vaccine's Serum-Free Rabies Vaccine Achieves Phase III Goals, Paving Way for Market Launch
第 1 页，共 1067 页
上一页
下一页
